Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 22, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Gateways to clinical trials.

A Tomillero, M A Moral

    Methods and Findings in Experimental and Clinical Pharmacology
    |June 27, 2009
    PubMed
    Summary
    This summary is machine-generated.

    This study reviews a comprehensive list of pharmaceutical agents, including small molecules, biologics, and vaccines, highlighting their therapeutic applications and development status. The findings provide a valuable resource for researchers and clinicians in drug discovery and development.

    Related Concept Videos

    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    Preclinical Development: Overview01:28

    Preclinical Development: Overview

    Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

    Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

    Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
    Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
    Drug Administration and Therapy Phases: Overview01:26

    Drug Administration and Therapy Phases: Overview

    Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
    The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
    The pharmacokinetic phase...
    Bioequivalence studies: Biowaivers01:13

    Bioequivalence studies: Biowaivers

    In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gateways to clinical trials.

    Methods and findings in experimental and clinical pharmacology·2011
    Same author

    Gateways to clinical trials.

    Methods and findings in experimental and clinical pharmacology·2011
    Same author

    Gateways to clinical trials.

    Methods and findings in experimental and clinical pharmacology·2010
    Same author

    Gateways to clinical trials.

    Methods and findings in experimental and clinical pharmacology·2010
    Same author

    Gateways to clinical trials.

    Methods and findings in experimental and clinical pharmacology·2010
    Same author

    Gateways to clinical trials.

    Methods and findings in experimental and clinical pharmacology·2010
    Same journal

    [Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Treatment algorithm for gastrointestinal graft-versus-host disease].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Classification of chronic graft-versus-host disease].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Pegfilgrastim in hematopoietic stem cell transplantation].

    Methods and findings in experimental and clinical pharmacology·2011
    Same journal

    [Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

    Methods and findings in experimental and clinical pharmacology·2011
    See all related articles

    Area of Science:

    • Pharmaceutical Sciences
    • Drug Discovery and Development
    • Medicinal Chemistry

    Context:

    • The landscape of pharmaceutical agents is vast and continually evolving.
    • Understanding the diverse range of therapeutic molecules, from small molecules to biologics and vaccines, is crucial for advancing medical treatments.
    • This review encompasses a broad spectrum of agents, including (-)-Gossypol, Abacavir sulfate/lamivudine, and Yttrium 90 (90Y) ibritumomab tiuxetan.

    Purpose:

    • To provide a comprehensive overview of various pharmaceutical agents currently in development or use.
    • To catalog and categorize different classes of drugs, including small molecules, monoclonal antibodies, and vaccines.
    • To serve as a reference for the status and potential applications of these agents in clinical practice and research.

    Summary:

    More Related Videos

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    Related Experiment Videos

    Last Updated: Jun 22, 2026

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    • The abstract lists numerous pharmaceutical agents, such as Agomelatine, Alemtuzumab, Bortezomib, Cetuximab, Daratumumab, Denosumab, Eribulin mesilate, Imatinib mesylate, Ipilimumab, Lenalidomide, Nivolumab, Palbociclib, Pembro-lizumab, Raltegravir potassium, Rivaroxaban, Sorafenib, Sunitinib, Trabectedin, Trifluridine/TPI, and Vorinostat.
    • It includes antiviral agents like Abacavir sulfate/lamivudine, Atazanavir sulfate, Darunavir, Etravirine, Fosamprenavir calcium, Lopinavir, Lopinavir/ritonavir, Tenofovir disoproxil fumarate, Tenofovir disoproxil fumarate/emtricitabine, and Tipranavir.
    • Vaccines such as ACAM-1000 (Smallpox (Vaccinia) Vaccine, Live) and immunomodulators like AGS-004, Belinostat, and Romiplostim are also mentioned.

    Impact:

    • Facilitates rapid identification of potential therapeutic agents for specific diseases.
    • Aids in understanding the breadth of pharmaceutical innovation across various medical fields.
    • Supports researchers in drug discovery by providing a consolidated list of agents and their associated therapeutic areas.